Copyright
©The Author(s) 2023.
World J Clin Cases. Dec 26, 2023; 11(36): 8542-8550
Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8542
Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8542
Symptoms | Sneller et al[12] | Davis et al[13] | Present in case described |
Fatigue | 26% | 98.3% | Yes |
Cough | 5% | 66.2% | Yes |
Concentration Deficit | 12% | 85.1% | Yes |
Dyspnea | 19% | 77.4% | Yes |
Anosmia/parosmia | 14% | 35.9% | No |
Headache | 12% | 77% | Yes |
Insomnia | 9% | 60% | No |
Chest pain/discomfort | 8% | 53.1% | No |
Anxiety | 6% | 57.9% | Yes |
Myalgia | 6% | 69.1% | Yes |
Tinnitus | 6% | 26.2% | No |
Palpitations | 5% | 67.4% | No |
Arthralgia | 3% | 52.2% | Yes |
Taste disorder | 5% | 33.7% | Yes |
Depression | 3% | 47.3% | Yes |
Alopecia | 4% | N/A | No |
Dizziness | 4% | 67.3% | No |
Paresthesias | 1% | 35.4% | Yes |
Visual Impairment | 1% | 10.4% | No |
- Citation: Oleson CV, Olsen AC, Shermon S. Spinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report. World J Clin Cases 2023; 11(36): 8542-8550
- URL: https://www.wjgnet.com/2307-8960/full/v11/i36/8542.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i36.8542